Your browser doesn't support javascript.
loading
Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial.
Lopes, Renato D; Alings, Marco; Connolly, Stuart J; Beresh, Heather; Granger, Christopher B; Mazuecos, Juan Benezet; Boriani, Giuseppe; Nielsen, Jens C; Conen, David; Hohnloser, Stefan H; Mairesse, Georges H; Mabo, Philippe; Camm, A John; Healey, Jeffrey S.
Afiliação
  • Lopes RD; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC. Electronic address: renato.lopes@duke.edu.
  • Alings M; Working Group on Cardiovascular Research, Utrecht, the Netherlands.
  • Connolly SJ; Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Canada.
  • Beresh H; Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Canada.
  • Granger CB; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC.
  • Mazuecos JB; Hospital Universitario Fundación Jimenez Díaz-Quironsalud, Madrid, Spain.
  • Boriani G; Cardiology Division, Department of Diagnostics, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena University Hospital, Modena, Italy.
  • Nielsen JC; Aarhus University Hospital, Aarhus, Denmark.
  • Conen D; Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Canada; Department of Medicine, University Hospital, Basel, Switzerland.
  • Hohnloser SH; Department of Cardiology, Johann Wolfgang Goethe University Hospital, Frankfurt, Germany.
  • Mairesse GH; Cliniques du Sud Luxembourg, Arlon, Belgium.
  • Mabo P; Hôpital Pontchaillou, Rennes, France.
  • Camm AJ; St George's University of London and Imperial College London, London, United Kingdom.
  • Healey JS; Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Canada.
Am Heart J ; 189: 137-145, 2017 Jul.
Article em En | MEDLINE | ID: mdl-28625370
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Marca-Passo Artificial / Pirazóis / Piridonas / Fibrilação Atrial / Tromboembolia Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Marca-Passo Artificial / Pirazóis / Piridonas / Fibrilação Atrial / Tromboembolia Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article